Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Secrest MH"'
Autor:
Secrest MH; Genentech, San Francisco, California; IQVIA Epidemiology & Drug Safety, Cambridge, Massachusetts., Phillips S; IQVIA Epidemiology & Drug Safety, Cambridge, Massachusetts. ORCID: https://orcid.org/0000-0001-9054-8587., Cepeda MS; Janssen Epidemiology, Titusville, New Jersey., Kern DM; Janssen Epidemiology, Titusville, New Jersey., Esposito DB; Ciconia, Inc., Westford; Department of Epidemiology, Boston University, Boston; HealthCore, Inc, Andover, Massachusetts., Wedin GP; Upsher-Smith Laboratories, LLC, Maple Grove, Minnesota.
Publikováno v:
Journal of opioid management [J Opioid Manag] 2023 Mar-Apr; Vol. 19 (2), pp. 99-110.
Autor:
Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA., Julian C; Genentech, Inc, South San Francisco, CA 94080, USA., Secrest MH; Genentech, Inc, South San Francisco, CA 94080, USA., Lee J; Genentech, Inc, South San Francisco, CA 94080, USA., Abajo-Guijarro AM; F Hoffmann-La Roche Ltd, Basel, Switzerland., McKenna E; Genentech, Inc, South San Francisco, CA 94080, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Jun; Vol. 18 (18), pp. 2233-2245. Date of Electronic Publication: 2022 Apr 20.
Autor:
Tan R; U.S. Medical Affairs, Genentech, Inc., South San Francisco, CA, USA., Yun C; U.S. Medical Affairs, Genentech, Inc., South San Francisco, CA, USA., Seetasith A; U.S. Medical Affairs, Genentech, Inc., South San Francisco, CA, USA., Sheinson D; U.S. Medical Affairs, Genentech, Inc., South San Francisco, CA, USA., Walls R; Safety and Risk Management, Product Development, F. Hoffmann-La Roche AG, Basel, Switzerland., Ngwa I; Safety and Risk Management, Product Development, F. Hoffmann-La Roche AG, Basel, Switzerland., Reddy JC; Safety and Risk Management, Product Development, F. Hoffmann-La Roche AG, Basel, Switzerland., Zhang Q; Personalized Healthcare Data Science, Global Product Development, Genentech, South San Francisco, CA, USA., Secrest MH; Personalized Healthcare Data Science, Global Product Development, Genentech, South San Francisco, CA, USA., Lambert P; Personalized Healthcare Data Science, Global Product Development, Genentech, South San Francisco, CA, USA., Sarsour K; Personalized Healthcare Data Science, Global Product Development, Genentech, South San Francisco, CA, USA.
Publikováno v:
The oncologist [Oncologist] 2022 Mar 11; Vol. 27 (3), pp. 236-243.
Autor:
Lindsay L; Personalized Healthcare, Data Science, Genentech, South San Francisco, California, USA lindsal1@gene.com., Secrest MH; Personalized Healthcare, Data Science, Genentech, South San Francisco, California, USA., Rizzo S; Personalized Healthcare, Data Science, Genentech, South San Francisco, California, USA., Keebler DS; Personalized Healthcare, Data Science, Genentech, South San Francisco, California, USA., Yang F; Roche Information Solutions, Roche Diagnostics International, Rotkreuz, Switzerland., Tsai L; Product Development, Genentech, South San Francisco, California, USA.
Publikováno v:
BMJ open [BMJ Open] 2021 Oct 01; Vol. 11 (10), pp. e051707. Date of Electronic Publication: 2021 Oct 01.
Autor:
Kern DM; Janssen Research & Development, LLC, Titusville, New Jersey., Cepeda MS; Janssen Research & Development, LLC, Titusville, New Jersey., Salas M; Daiichi-Sankyo, Clinical Safety and Pharmacovigilance, and Epidemiology, Basking Ridge, New Jersey.; University of Pennsylvania Perelman School of Medicine, CCEB/CPeRT, Philadelphia, Pennsylvania., Phillips S; IQVIA Epidemiology & Drug Safety, Seattle, Washington., Secrest MH; IQVIA Epidemiology & Drug Safety, Cambridge, Massachusetts., Wedin GP; Upsher-Smith Laboratories, LLC, Pharmacovigilance & Risk Management, Maple Grove, Minnesota, USA.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2020 Sep 01; Vol. 21 (9), pp. 1818-1824.
Autor:
Secrest MH; IQVIA Epidemiology & Drug Safety, Cambridge, MA, USA., Storm M; Agios Pharmaceuticals Inc., Cambridge, MA, USA., Carrington C; IQVIA Epidemiology & Drug Safety, Cambridge, MA, USA., Casso D; IQVIA Epidemiology & Drug Safety, Seattle, WA, USA., Gilroy K; Agios Pharmaceuticals Inc., Cambridge, MA, USA., Pladson L; Agios Pharmaceuticals Inc., Cambridge, MA, USA., Boscoe AN; Agios Pharmaceuticals Inc., Cambridge, MA, USA.
Publikováno v:
European journal of haematology [Eur J Haematol] 2020 Aug; Vol. 105 (2), pp. 173-184. Date of Electronic Publication: 2020 Jun 23.
Autor:
Secrest MH; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Canada., Platt RW; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.; Department of Pediatrics, McGill University, Montreal, Canada., Dormuth CR; Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada., Chateau D; Department of Community Health Sciences, Manitoba Centre for Health Policy, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada., Targownik L; Department of Community Health Sciences, Manitoba Centre for Health Policy, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada., Nie R; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Canada., Doyle CM; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada., Dell'Aniello S; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Canada., Filion KB; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.; Division of Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Canada.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Jan; Vol. 29 Suppl 1, pp. 26-34. Date of Electronic Publication: 2019 Jan 09.
Autor:
Secrest MH; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Azoulay L; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada., Dahl M; Department of Community Health Sciences, Manitoba Centre for Health Policy, Winnipeg, Manitoba, Canada., Clemens KK; Department of Medicine, and Epidemiology and Biostatistics, Western University, London, Ontario, Canada.; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Lawson Health Research Institute, London, Ontario, Canada., Durand M; Internal Medicine Service, Centre Hospitalier Universitaire de Montreal (CHUM), Montreal, Quebec, Canada., Hu N; The Health Quality Council, Saskatoon, Saskatchewan, Canada., Targownik L; Department of Community Health Sciences, Manitoba Centre for Health Policy, Winnipeg, Manitoba, Canada.; Section of Gastroenterology, Division of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Turin TC; Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada., Dormuth CR; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada., Filion KB; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; Department of Medicine, McGill University, Montreal, Quebec, Canada.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Jan; Vol. 29 Suppl 1, pp. 86-92. Date of Electronic Publication: 2019 Aug 28.
Autor:
Wu JW; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada., Azoulay L; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada., Huang A; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Paterson M; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada., Wu F; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Secrest MH; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada., Filion KB; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.; Division of Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Jan; Vol. 29 Suppl 1, pp. 78-85. Date of Electronic Publication: 2018 Oct 04.
Autor:
Secrest MH; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Platt RW; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; Department of Pediatrics, McGill University, Montreal, Quebec, Canada., Reynier P; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Dormuth CR; Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Benedetti A; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Center, Montreal, Quebec, Canada., Filion KB; Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; Division of Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Jan; Vol. 29 Suppl 1, pp. 35-44. Date of Electronic Publication: 2019 Sep 04.